{
    "2021-03-03": [
        [
            {
                "time": "",
                "original_text": "微创医疗亏损12-13亿元 药物球囊增长显著 亏损",
                "features": {
                    "keywords": [
                        "微创医疗",
                        "亏损",
                        "药物球囊",
                        "增长"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "2020医疗器械上市公司业绩前瞻：95%预盈，9家净利润增速超1倍",
                "features": {
                    "keywords": [
                        "医疗器械",
                        "上市公司",
                        "业绩",
                        "预盈",
                        "净利润",
                        "增速"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "46家机构，高瓴调研！这只千亿白马能否成为下一个机构抱团股？",
                "features": {
                    "keywords": [
                        "机构",
                        "高瓴",
                        "调研",
                        "白马股",
                        "抱团"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "2021Q1，多数医药企业业绩或普遍高增",
                "features": {
                    "keywords": [
                        "医药企业",
                        "业绩",
                        "高增"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "波士顿咨询：十大具备全球挑战者的国产医械厂商",
                "features": {
                    "keywords": [
                        "波士顿咨询",
                        "全球挑战者",
                        "国产医械厂商"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}